Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Davis

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccinesH L Davis, M J McCluskie, J L Gerin, et al.
Human Gene Therapy|December 1, 1993
Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscleH L Davis, B A Demeneix, B Quantin, et al.
FEMS Immunology and Medical Microbiology|December 26, 2001
CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young miceR D Weeratna, C L Brazolot Millan, M J McCluskie, et al.
Oligonucleotides|July 2, 2005
Quantification of oligodeoxynucleotides in human plasma with a novel hybridization assay offers greatly enhanced sensitivity over capillary gel electrophoresisS M Efler, L Zhang, B O Noll, et al.
Gene Therapy|February 1, 2002
Designing gene therapy vectors: avoiding immune responses by using tissue-specific promotersR D Weeratna, T Wu, S M Efler, et al.
Intervirology|March 17, 2001
Optimization strategies for DNA vaccinesR D Weeratna, M J McCluskie, L Comanita, et al.
Vaccine|December 1, 1994
Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigenH L Davis, M L Michel, M Mancini, et al.
Radiology|February 1, 1977
Stage III ovarian carcinoma: treatment and results. Comparison of multiple drugs, a single drug, and irradiationD A Buchler, J C Kline, H L Davis, et al.
Annals of the New York Academy of Sciences|November 27, 1995
DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune responseR G Whalen, C Leclerc, E Dériaud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 yearsC L Cooper, J B Angel, I Seguin, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccinesH L Davis, M J McCluskie, J L Gerin, et al.
Human Gene Therapy|December 1, 1993
Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscleH L Davis, B A Demeneix, B Quantin, et al.
FEMS Immunology and Medical Microbiology|December 26, 2001
CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young miceR D Weeratna, C L Brazolot Millan, M J McCluskie, et al.
Oligonucleotides|July 2, 2005
Quantification of oligodeoxynucleotides in human plasma with a novel hybridization assay offers greatly enhanced sensitivity over capillary gel electrophoresisS M Efler, L Zhang, B O Noll, et al.
Gene Therapy|February 1, 2002
Designing gene therapy vectors: avoiding immune responses by using tissue-specific promotersR D Weeratna, T Wu, S M Efler, et al.
Intervirology|March 17, 2001
Optimization strategies for DNA vaccinesR D Weeratna, M J McCluskie, L Comanita, et al.
Vaccine|December 1, 1994
Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigenH L Davis, M L Michel, M Mancini, et al.
Radiology|February 1, 1977
Stage III ovarian carcinoma: treatment and results. Comparison of multiple drugs, a single drug, and irradiationD A Buchler, J C Kline, H L Davis, et al.
Annals of the New York Academy of Sciences|November 27, 1995
DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune responseR G Whalen, C Leclerc, E Dériaud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 yearsC L Cooper, J B Angel, I Seguin, et al.
Pageof 17